Low rectal cancer : aspects of surgical techniques and treatment results by Anderin, Claes
	  Institutionen	  för	  molekylär	  medicin	  och	  kirurgi	  
Low rectal cancer - 
Aspects of surgical techniques and 
treatment results 
AKADEMISK AVHANDLING 
som för avläggande av medicine doktorsexamen vid Karolinska 
Institutet offentligen försvaras i Rolf Luft Auditorium, Karolinska 
Universitetssjukhuset 
Fredagen den 20 januari, 2012, kl. 09.00 
av 
Claes	  Anderin	  
Leg. läkare 
Huvudhandledare:  
Docent Torbjörn Holm 
Karolinska Institutet	  
Institutionen för molekylär  
medicin och kirurgi 
 
 
	  
Bihandledare:	   
Docent Anna Martling 
Karolinska Institutet 
Institutionen för molekylär  
medicin och kirurgi 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Stockholm 2012	  
Fakultetsopponent:	  
Docent Jörgen Rutegård 
Umeå Universitet  
Institutionen för kirurgisk och perioperativ 
vetenskap 
	  
Betygsnämnd:	  
Docent Olof Hallböök 
Linköpings Universitet 
Institutionen för klinisk och  
experimentell medicin 
 
 
Professor Per-Olof Nyström 
Karolinska Institutet 
Institutionen för klinisk vetenskap,  
intervention och teknik 
 
 
Docent, Emeritus Åke Öst 
Karolinska Institutet 
 
	  
ABSTRACT ______________________________
    
About one third of all patients diagnosed with rectal cancer have a low tumour (i.e. 0-5 cm from the anal 
verge). Abdominoperineal excision (APE) is the most common surgical procedure in low rectal cancer, 
performed in approximately 80% of patients. While oncological outcomes in rectal cancer have improved 
in recent decades, the outcome after APE has remained poor and local recurrence rates have been reported 
in up to 23% of cases. This may be explained by technical difficulties encountered during APE, resulting 
in tumour perforations and positive circumferential resection margins. Moreover, many patients have a 
complicated postoperative recovery, marked by perineal wound complications. The APE technique has 
recently changed to a more radical procedure, entailing an extralevator approach (ELAPE), in an attempt 
to improve oncological outcomes. 
The aim of this thesis was to evaluate different surgical techniques in patients with low rectal cancer. 
 
The objective of Paper I was to assess treatment and outcome in patients operated for low rectal cancer, 
focusing on differences related to the type of resection. All patients diagnosed with low rectal cancer from 
1995 to 2003 in Stockholm were included in the study (n=613). The surgical procedures performed were 
APE, anterior resection (AR) and Hartmann’s procedure. Clinical data, including data on histopathology 
and outcome, were analysed in relation to the type of surgery performed. The study showed that 
intraoperative bowel perforation (IOP) was more common after APE (12%) than AR (4%) and 
Hartmann’s procedure (9%); p=0.03. Incomplete tumour clearance was also more common in the APE 
group (18%) than in the AR (5%) or Hartmann groups (14%); p<0.01. Although local control and survival 
were poorer after APE than after AR, the type of operation per se was not an independent prognostic 
factor. 
 
In Paper II the objectives were to investigate if ELAPE improved oncological outcomes compared with 
standard APE (SAPE) and to analyse the morbidity associated with ELAPE. In this multicentre study, 176 
ELAPE operations, performed by 11 European colorectal surgeons, were compared with 124 SAPE from 
one centre in the United Kingdom. Clinical and histopathological data were collected along with specimen 
photographs. Tissue morphometry was also performed on the distal ten slices of the specimen. The results 
showed that ELAPE removed more tissue from outside the smooth muscle layer per slice (median area 
2120 versus 1259 mm2; p<0.001), leading to a reduction in the involved circumferential resection margin 
(CRM) (from 49.6 to 20.3%; p<0.001) and the intraoperative bowel perforation (IOP) (from 28.2 to 8.2%; 
p<0.001) compared with SAPE. However, ELAPE was also associated with an increased frequency of 
perineal wound complications (from 20 to 38%; p=0.019) compared with SAPE. 
 
The objective of Paper III was to evaluate short-term outcomes with a gluteus maximus myocutaneous 
flap reconstruction (GMF) of the pelvic floor after ELAPE for low rectal cancer. The study included 65 
consecutive patients operated with ELAPE and a one-sided GMF for low or locally recurrent rectal cancer 
at the Karolinska University Hospital between 2002 and 2008. All perineal complications occurring within 
30 days after surgery were registered. In addition, the status of the perineal reconstruction at 6 months and 
1 year after surgery was assessed based on medical records. The result showed that 41.5% had one or 
more perineal wound complications. Most common was a minor wound infection, occurring in 23.1% 
patients, while 18.4% had either a more severe infection with dehiscence or a pelvic abscess. The 
reconstruction was completely healed in 91% of the patients at 1 year after surgery. 
 
With SAPE the patient remains in the supine position during the perineal part of the procedure. However, 
turning the patient into the prone position may improve visualisation which could potentially reduce the 
risk of involved CRM and IOP and, thereby, improve local control. The objective of Paper IV was to 
evaluate local recurrence rates after APE in relation to the positioning of the patient during the perineal 
part of the procedure. This cohort study included 466 patients operated with APE for low rectal cancer in 
Stockholm from 2001 to 2010. The study showed an incomplete resection in 12.4% of the patients after 
APE in the supine position and in 6.8% after APE in the prone position (p=0.038). Corresponding figures 
for IOP were 12.4% and 4.0% (p<0.001). Prone APE was associated with a 39% relative reduction rate in 
local recurrence events compared with APE in the supine position. However, this difference was not 
statistically significant, HR 0.61, (95% CI: 0.27-1.37). 
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